Oppenheimer reiterated their buy rating on shares of Centene (NYSE:CNC) in a report released on Friday morning. Oppenheimer currently has a $111.00 target price on the stock.

A number of other brokerages have also recently issued reports on CNC. Deutsche Bank restated a buy rating and set a $111.00 target price (up previously from $95.00) on shares of Centene in a research report on Thursday, September 14th. Zacks Investment Research upgraded shares of Centene from a hold rating to a buy rating and set a $107.00 price target for the company in a report on Friday, September 15th. Jefferies Group lifted their price target on shares of Centene from $98.00 to $112.00 and gave the stock a buy rating in a report on Friday, October 13th. Credit Suisse Group started coverage on shares of Centene in a report on Thursday, November 2nd. They set a neutral rating and a $102.00 price target for the company. Finally, Cowen reiterated a buy rating and set a $115.00 price target on shares of Centene in a report on Tuesday, October 24th. One analyst has rated the stock with a sell rating, three have given a hold rating and seventeen have given a buy rating to the company’s stock. Centene currently has an average rating of Buy and an average price target of $99.11.

Shares of Centene (NYSE:CNC) traded down $4.16 during midday trading on Friday, hitting $94.86. 4,127,504 shares of the company traded hands, compared to its average volume of 1,270,874. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.99 and a quick ratio of 0.99. Centene has a 12-month low of $54.40 and a 12-month high of $103.15. The firm has a market capitalization of $17,087.53, a PE ratio of 18.86, a price-to-earnings-growth ratio of 1.51 and a beta of 0.71.

Centene (NYSE:CNC) last announced its earnings results on Tuesday, October 24th. The company reported $1.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.11. The company had revenue of $11.90 billion during the quarter, compared to analysts’ expectations of $11.75 billion. Centene had a net margin of 1.81% and a return on equity of 14.79%. The firm’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.12 earnings per share. research analysts forecast that Centene will post 4.98 earnings per share for the current fiscal year.

In related news, Director Robert K. Ditmore sold 4,167 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The shares were sold at an average price of $90.42, for a total value of $376,780.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.00% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CNC. Municipal Employees Retirement System of Michigan grew its stake in Centene by 45.7% during the second quarter. Municipal Employees Retirement System of Michigan now owns 7,910 shares of the company’s stock worth $632,000 after buying an additional 2,480 shares during the period. IFP Advisors Inc grew its stake in Centene by 9.6% during the second quarter. IFP Advisors Inc now owns 1,944 shares of the company’s stock worth $155,000 after buying an additional 170 shares during the period. Global X Management Co. LLC grew its stake in Centene by 32.9% during the second quarter. Global X Management Co. LLC now owns 6,046 shares of the company’s stock worth $483,000 after buying an additional 1,496 shares during the period. Schwab Charles Investment Management Inc. grew its stake in Centene by 28.8% during the second quarter. Schwab Charles Investment Management Inc. now owns 788,573 shares of the company’s stock worth $62,992,000 after buying an additional 176,403 shares during the period. Finally, DekaBank Deutsche Girozentrale grew its stake in Centene by 11.3% during the second quarter. DekaBank Deutsche Girozentrale now owns 39,220 shares of the company’s stock worth $3,195,000 after buying an additional 3,969 shares during the period. Institutional investors own 92.33% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/12/16/centene-cnc-given-buy-rating-at-oppenheimer.html.

Centene Company Profile

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.

Analyst Recommendations for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.